Suparma Tbk (SPMA) - Total Liabilities
Based on the latest financial reports, Suparma Tbk (SPMA) has total liabilities worth Rp1.07 Trillion IDR (≈ $62.42 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Suparma Tbk generate cash to assess how effectively this company generates cash.
Suparma Tbk - Total Liabilities Trend (2000–2024)
This chart illustrates how Suparma Tbk's total liabilities have evolved over time, based on quarterly financial data. Check SPMA cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Suparma Tbk Competitors by Total Liabilities
The table below lists competitors of Suparma Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nam Liong Global Corp
TWO:5450
|
Taiwan | NT$1.72 Billion |
|
Corentec Co Ltd
KQ:104540
|
Korea | ₩90.03 Billion |
|
Birla Cable Limited
NSE:BIRLACABLE
|
India | Rs1.62 Billion |
|
IRSA Propiedades Comerciales S.A
BA:IRCP
|
Argentina | AR$103.30 Billion |
|
Entera Bio Ltd
NASDAQ:ENTX
|
USA | $2.17 Million |
|
Wallbox NV
NYSE:WBX
|
USA | $280.35 Million |
|
Guandian Defense Technology Co. Ltd. A
SHG:688287
|
China | CN¥61.89 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Suparma Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SPMA company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Suparma Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Suparma Tbk (2000–2024)
The table below shows the annual total liabilities of Suparma Tbk from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp1.01 Trillion ≈ $59.07 Million |
+2.39% |
| 2023-12-31 | Rp984.50 Billion ≈ $57.69 Million |
-9.92% |
| 2022-12-31 | Rp1.09 Trillion ≈ $64.04 Million |
+17.43% |
| 2021-12-31 | Rp930.68 Billion ≈ $54.53 Million |
+18.61% |
| 2020-12-31 | Rp784.67 Billion ≈ $45.98 Million |
-21.11% |
| 2019-12-31 | Rp994.59 Billion ≈ $58.28 Million |
-3.27% |
| 2018-12-31 | Rp1.03 Trillion ≈ $60.25 Million |
+2.47% |
| 2017-12-31 | Rp1.00 Trillion ≈ $58.80 Million |
-7.06% |
| 2016-12-31 | Rp1.08 Trillion ≈ $63.27 Million |
-24.64% |
| 2015-12-31 | Rp1.43 Trillion ≈ $83.96 Million |
+11.30% |
| 2014-12-31 | Rp1.29 Trillion ≈ $75.43 Million |
+27.26% |
| 2013-12-31 | Rp1.01 Trillion ≈ $59.27 Million |
+14.32% |
| 2012-12-31 | Rp884.86 Billion ≈ $51.85 Million |
+10.56% |
| 2011-12-31 | Rp800.32 Billion ≈ $46.90 Million |
+3.72% |
| 2010-12-31 | Rp771.65 Billion ≈ $45.22 Million |
+3.73% |
| 2009-12-31 | Rp743.87 Billion ≈ $43.59 Million |
-17.63% |
| 2008-12-31 | Rp903.07 Billion ≈ $52.92 Million |
+9.36% |
| 2007-12-31 | Rp825.76 Billion ≈ $48.39 Million |
-11.47% |
| 2006-12-31 | Rp932.70 Billion ≈ $54.65 Million |
+1.97% |
| 2005-12-31 | Rp914.65 Billion ≈ $53.60 Million |
-0.10% |
| 2004-12-31 | Rp915.55 Billion ≈ $53.65 Million |
+13.02% |
| 2003-12-31 | Rp810.05 Billion ≈ $47.47 Million |
-2.72% |
| 2002-12-31 | Rp832.71 Billion ≈ $48.79 Million |
+8.33% |
| 2001-12-31 | Rp768.71 Billion ≈ $45.04 Million |
+18.73% |
| 2000-12-31 | Rp647.46 Billion ≈ $37.94 Million |
-- |
About Suparma Tbk
PT Suparma Tbk manufactures and sells paper and related paper products in Indonesia. The company's paper products include laminated wrapping and brown Kraft papers; sandwiched ribbed Kraft recycle papers; and coated duplex boards. It also offers bathroom, facial, napkin, and carrier tissues; cocktail, dinner, and luncheon napkins. In addition, the company provides hand, hand roll, industrial and … Read more